The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment

INTRODUCTION: An Alzheimer's disease (AD) biomarker adjusted for age-related brain changes should improve specificity for AD-related pathological burden. METHODS: We calculated a brain-age-adjusted “personalized AD cortical thickness index” (pADi) in mild cognitive impairment patients from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Racine, Annie M., Brickhouse, Michael, Wolk, David A., Dickerson, Bradford C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Special Section: State of the Field: Advances in Neuroimaging from the 2017 Alzheimer’s Imaging Consortium. (Guest Editors: Drs. David Wolk, Victor Villemagne & Bradford Dickerson)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956936/
https://www.ncbi.nlm.nih.gov/pubmed/29780874
http://dx.doi.org/10.1016/j.dadm.2018.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956936/
https://www.ncbi.nlm.nih.gov/pubmed/29780874
http://dx.doi.org/10.1016/j.dadm.2018.02.007

Ejemplares similares